Clinical study and pharmaco - economic evaluation of certain supplemental drugs used for anemia of chronic renal failure (CRF) in Egypt /
Amal Abdelaal Abdelbakey Elkhamery
Clinical study and pharmaco - economic evaluation of certain supplemental drugs used for anemia of chronic renal failure (CRF) in Egypt / دراسة إكلينيكية وتقييم للتكلفة العلاجية المقارن بالاستجابة لبعض العقارات المساعدة فى علاج أنيميا الفشل الكلوى المزمن فى مصر Amal Abdelaal Abdelbakey Elkhamery ; Supervised Mohamed Aly Kassem , Moustafa Mahmoud Noshy - Cairo : Amal Abdelaal Abdelbakey Elkhamery , 2012 - 206 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic renal failure is one of the highly spread diseases in Egypt . Haemodialysis in its classic form is the most common treatment . In dialysis patients , normocytic and normochromic anemia appears . The reason of this case is multi - factorial although lack of endogenous erythropoietin by diseased kidneys is the most important factor . This can be managed by administrantion of recombinant human erythropoietin after assessment of patient nutrition and iron stores
Chronic renal failure L - carnitine Recombinant human erythropoietin
Clinical study and pharmaco - economic evaluation of certain supplemental drugs used for anemia of chronic renal failure (CRF) in Egypt / دراسة إكلينيكية وتقييم للتكلفة العلاجية المقارن بالاستجابة لبعض العقارات المساعدة فى علاج أنيميا الفشل الكلوى المزمن فى مصر Amal Abdelaal Abdelbakey Elkhamery ; Supervised Mohamed Aly Kassem , Moustafa Mahmoud Noshy - Cairo : Amal Abdelaal Abdelbakey Elkhamery , 2012 - 206 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic renal failure is one of the highly spread diseases in Egypt . Haemodialysis in its classic form is the most common treatment . In dialysis patients , normocytic and normochromic anemia appears . The reason of this case is multi - factorial although lack of endogenous erythropoietin by diseased kidneys is the most important factor . This can be managed by administrantion of recombinant human erythropoietin after assessment of patient nutrition and iron stores
Chronic renal failure L - carnitine Recombinant human erythropoietin